Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 15;7(1):66-75.
doi: 10.3945/an.115.010207. Print 2016 Jan.

Impact of Obesity and Metabolic Syndrome on Immunity

Affiliations
Review

Impact of Obesity and Metabolic Syndrome on Immunity

Catherine J Andersen et al. Adv Nutr. .

Abstract

Obesity is associated with metabolic disturbances that cause tissue stress and dysfunction. Obese individuals are at a greater risk for chronic disease and often present with clinical parameters of metabolic syndrome (MetS), insulin resistance, and systemic markers of chronic low-grade inflammation. It has been well established that cells of the immune system play an important role in the pathogenesis of obesity- and MetS-related chronic diseases, as evidenced by leukocyte activation and dysfunction in metabolic tissues such as adipose tissue, liver, pancreas, and the vasculature. However, recent findings have highlighted the substantial impact that obesity and MetS parameters have on immunity and pathogen defense, including the disruption of lymphoid tissue integrity; alterations in leukocyte development, phenotypes, and activity; and the coordination of innate and adaptive immune responses. These changes are associated with an overall negative impact on chronic disease progression, immunity from infection, and vaccine efficacy. This review presents an overview of the impact that obesity and MetS parameters have on immune system function.

PubMed Disclaimer

Conflict of interest statement

Author disclosures: CJ Andersen, KE Murphy, and ML Fernandez, no conflict of interest.

Figures

FIGURE 1
FIGURE 1
The impact of obesity and MetS on immune system function. Obesity and MetS are associated with stress and dysfunction of metabolic tissues, including adipose tissue, liver, skeletal muscle, and pancreas. Systemic physiological dysfunction that arises from obesity-related complications leads to fat accumulation in primary lymphoid organs (bone marrow and thymus), resulting in a breakdown of tissue architecture and integrity. Obesity-induced changes in lymphoid tissues are further associated with an altered distribution of leukocyte subsets and populations and greater numbers of leukocytes with proinflammatory phenotypes. Obesity-induced disruptions in the immune system impair immunity and contribute to the progression of metabolic dysfunction and chronic disease. Chronic disease can further perpetuate dysfunction throughout the immune system. MetS, metabolic syndrome.

References

    1. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001;161:1581–6. - PubMed
    1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97. - PubMed
    1. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005;12:295–300. - PubMed
    1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief 2012;82:1–8. - PubMed
    1. Jia H, Lubetkin EI. Trends in quality-adjusted life-years lost contributed by smoking and obesity. Am J Prev Med 2010;38:138–44. - PubMed